|Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer.|
|PMID: 8634959 Owner: NLM Status: MEDLINE|
|The prediction of susceptibility to heritable breast, ovarian and colon cancer raises important legal and ethical concerns. Health care professionals have a duty to disclose sufficient information to enable patients to make informed decisions. They must also safeguard the confidentiality of patient data. These duties may come into conflict if a positive finding in one patient implies that family members are also at risk. A legal distinction is made between a breach of confidentiality and the legitimate sharing of information in a patient's interest or to prevent harm to a third party. Physicians also have a fiduciary duty to warn. Other issues concern the legal liability assumed by genetic counsellors, whose disclosures may influence decisions about childbearing, for example, and the risk of socioeconomic discrimination faced by people with a known genetic susceptibility. Traditional ethical orientations and principals may be applied to these and other questions, but feminist ethics will likely have particular importance in the development of an ethical stance toward testing and counseling for heritable breast and ovarian cancer.|
|B M Dickens; N Pei; K M Taylor|
Related Documents :
|1831399 - Isolated incisional metastases after intraperitoneal radioactive chromic phosphate ther...
19615029 - Perforating cutaneous metastasis from an ovarian adenocarcinoma.
17916899 - The alarm anti-protease, secretory leukocyte protease inhibitor, is a proliferation and...
3364939 - Multiple parameter analyses of human ovarian cancer: morphology, immunohistochemistry, ...
12193109 - Endothelin-1 acts as a survival factor in ovarian carcinoma cells.
9863919 - Significance of tissue polypeptide specific antigen (tps) in diagnosis and monitoring o...
23057289 - Delayed presentation of breast cancer patients.
23820059 - Predictors of pathological progression among men with localized prostate cancer undergo...
6785319 - Megaloblastic anaemia after pelvic radiotherapy for carcinoma of the cervix.
|Type: Journal Article|
|Title: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne Volume: 154 ISSN: 0820-3946 ISO Abbreviation: CMAJ Publication Date: 1996 Mar|
|Created Date: 1996-07-10 Completed Date: 1996-07-10 Revised Date: 2009-11-19|
Medline Journal Info:
|Nlm Unique ID: 9711805 Medline TA: CMAJ Country: CANADA|
|Languages: eng Pagination: 813-8 Citation Subset: AIM; E; IM|
|Faculty of Law, University of Toronto, Ontario.|
|APA/MLA Format Download EndNote Download BibTex|
Breast Neoplasms / genetics*
Colonic Neoplasms / genetics*
Genetic Counseling / legislation & jurisprudence*
Genetic Predisposition to Disease
Genetic Testing / legislation & jurisprudence*
Ovarian Neoplasms / genetics*
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Integrated delivery systems: has their time come in Canada?
Next Document: Direct and indirect costs of asthma in Canada, 1990.